About
Cancer Immunotherapy
Areas of Focus
Categories
Biologics & Biopharmaceutical
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
1,149
By Phase
PHASE2/PHASE3: 1PHASE2: 5PHASE3: 2
By Status
COMPLETED: 8
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT03610360Lead Sponsor
DENdritic Cell Immunotherapy for Mesothelioma
PHASE2/PHASE3Completed
176 participants
Started: Jun 21, 2018 · Completed: Jun 30, 2022
NCT03210740Lead Sponsor
Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis
PHASE2Completed
30 participants
Started: Jun 6, 2017 · Completed: Apr 24, 2018
NCT03005964Lead Sponsor
Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis
PHASE2Completed
74 participants
Started: Dec 31, 2016 · Completed: Sep 4, 2017
NCT01938599Lead Sponsor
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
PHASE2Completed
92 participants
Started: Aug 31, 2013 · Completed: Aug 31, 2014
NCT01696799Lead Sponsor
Comparative PK Study of Econazole Nitrate Foam and Econazole Nitrate Cream in Subjects With Interdigital Tinea Pedis Aged 12 Years to Less Than 18 Years
PHASE2Completed
42 participants
Started: Sep 30, 2011 · Completed: Aug 31, 2012
Locations (1)
Headquarters
s-Hertogenbosch, Netherlands
Map
Loading map...